1987
DOI: 10.1007/bf00216004
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal desipramine or zimeldine treatment causes long-lasting changes in brain monoaminergic systems and alcohol related behavior in rats

Abstract: To study the relationship between neonatal antidepressant administration, active (REM) sleep and adult alcohol-related behavior, rat pups were treated daily with 5 mg/kg desipramine (DMI) or 25 mg/kg zimeldine SC from the 6th to the 19th postnatal days. Movement sensitive mattress ("SCSB") measurements showed that zimeldine treatment suppressed active sleep throughout the whole treatment period, but DMI was more effective during the first 8 days than during the last treatment days. At the age of 70 days, the z… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
18
1

Year Published

1987
1987
2005
2005

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 36 publications
(20 citation statements)
references
References 39 publications
1
18
1
Order By: Relevance
“…The neonatal clomipramine administration has been reported to produce a lifelong increase in REM sleep, impaired sexual activity and diminished aggressive behavior in mature rats (Mirmiran et al, 1981;Hilakivi et al, 1987;Vogel et al, 1988). These abnormalities are analogous to that frequently seen in humans with endogenous depression.…”
Section: Discussionmentioning
confidence: 78%
“…The neonatal clomipramine administration has been reported to produce a lifelong increase in REM sleep, impaired sexual activity and diminished aggressive behavior in mature rats (Mirmiran et al, 1981;Hilakivi et al, 1987;Vogel et al, 1988). These abnormalities are analogous to that frequently seen in humans with endogenous depression.…”
Section: Discussionmentioning
confidence: 78%
“…This is certainly not the first study to evaluate changes in the serotonin system following neonatal antidepressant treatment. Previous studies have shown that following neonatal exposure to clomipramine, zimelidine, or desipramine, several brain regions in adult rats exhibit reductions in extracellular concentrations of serotonin (Hilakivi et al, 1987b;Feenstra et al, 1996;Vijayakumar and Meti, 1999). Moreover, early administration of clomipramine or Lu-10-134C, a putative SSRI, produces a downregulation of DR SERT mRNA levels in adult rats (Hansen and Mikkelsen, 1998), and in some cases reduces the baseline firing rate of DR neurons (Kinney et al, 1997).…”
Section: Discussionmentioning
confidence: 97%
“…In all brain parts studied the concentrations of dopamine and its metabolites were about similar in the nomifensine-treated and in the control rats, whereas in the previous study (Hilakivi et al, 1987) the concentration of dopamine was reduced by neonatal treatment with zimeldine and desipramine in the hypothalamus, and in the case of zimeldine also in the neostriatum and limbic forebrain. Turnover of dopamine in the nomifensine rats in the present study, however, tended to be decreased in the neostriatum and tl~e limbic forebrain as shown by decreased DOPAC/DA ratios.…”
Section: Discussionmentioning
confidence: 77%
“…In earlier studies neonatal active sleep was also found to be reduced by early desipramine, zimeldine (Hilakivi et al, 1987) and clomipramine (Mirmiran et al, 1981) exposures. The amount of quiet state, however, was increased by desipramine and zimeldine exposures, and clomipramine did not affect it.…”
Section: Discussionmentioning
confidence: 85%
See 1 more Smart Citation